Altered MicroRNAs In Sera May Be Markers Of Gray Matter Lesion Demyelination In Patients With MS, Study Indicates

Neurology Advisor (5/25, Akirov) reports researchers found “altered microRNAs (miRNAs) detected in sera may be used as markers of gray matter lesion demyelination in patients with multiple sclerosis (MS).” The findings were published in Annals of Clinical...